Who we are :
Based on 10 years of scientific research, NETRI has developped a unique know-how in designing multiple organs/organoids on chip by integrating disruptive building blocks into the same microfluidic devices, while maintaining industrial production stantards compatible with pharmaceutical industry equipments.
Thanks to our patented technologies, we are capable of manufacturing prototypes and validate their biological functions using rodent or human cells. Our unique infrastructure allows us also to scale up chip production for mass production.
Our standard or customer-inspired devices are designed to accelerate the development time for new treatments by :
Translating human physiology into organ on chip with high throughput industrial capacity
Ensuring reproducible readouts for mode of action exploration, including axonal transport, growth, regeneration and axotomy, synaptic toxicity, viral and protein propagation, organoids and electrophysiological recordings
Developping robust, automated and parallelised organ on chip technologies applicable in industry, with medium to high throughput capacity, reliability and repeatability, using validated and standardised tools and methods.
Products
Translate human physiology into organ on chips. On-demand training with connected goggles
Latest News
Keep in touch with us and read about our latest news.
NETRI présenté dans la Gazette du Laboratoire
La Gazette du Laboratoire consacre un article à Netri dans son n°273 de Mars 2021. L'occasion de découvrir nos technologies innovantes et leurs applications. Découvrez les ici.
NETRI mis en avant dans Les Echos
L'article paru dans Les Echos met en avant NETRI et ses projets de développement. Consulter l'article ici.
NETRI received the Global Health & Pharma’s 2020 Biotechnology Awards
NETRI is honored to receive the Global Health Pharma's Biotechnology Award 2020. The GHP Biotechnology Awards recognize and highlight the companies within the healthcare biotechnology industry. Learn more about the GHP Biotechnology Awards here.